NEW YORK (GenomeWeb News) - Molecular diagnostics company BG Medicine will collaborate with researchers in Denmark and use data from various cohort studies conducted in Copenhagen in its High Risk Plaque Initiative, the company said today.
 
The HRP is a research initiative begun by BG Medicine, Merck, AstraZeneca, and Philips that aims to develop diagnostic biomarkers that can predict heart attacks caused by myocardial infarction or by the rupture of atherosclerotic plaque as early as four years before they occur. 
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.